We are looking for a Senior Director Global Business Development to join the Business Development and Licensing Team (BD&L) at our operational headquarters in Glattbrugg, Zurich. As an expert in finance and business modelling with emphasis on development stage life sciences companies, products and services you will report to the Head of BD&L and be responsible for, but not limited to, the following:
Seek out and generate data required to build robust BD&L business cases (financial models) that are aligned with insights generated during the due diligence process
Manage research including external consultants or service providers (recruitment, briefing, definition of deliverables, etc.)
Collaborate closely with stakeholders and data providers of adjacent departments, namely Market Analytics, Medical Affairs, Regulatory, Market Access and Clinical Development
Create, own and present content for investment opportunities to the Executive Committee. Support the development of BD&L updates to the Board of Directors of Vifor Pharma
Be the “project owner” in regards to BD&L opportunities assigned to you and ensure the transition of those business cases to Corporate Finance and the implementation of operational activities in Project Management once a deal is closed
Support efforts to identify new companies, new products and services and ultimately new investment ideas that are in alignment with the strategic needs of the Vifor Pharma Group
Create your own network of internal and external partners
Be part of a BD&L department and participate with team members in the early evaluation and project triage of newly identified opportunities (deal flow)
You bring strong analytical and conceptual skills. You enjoy creating your own models in Excel and expressing your findings by creating a convincing storyline. Specifically, we are looking for a person with the following profile:
University degree in Biology/Chemistry/Medicine or equivalent natural or medical sciences higher education
Further business and administration education (e.g. MBA) and/or
Financial Analysis (e.g. CFA) is an important additional asset 7-10 years of professional experience in a Pharma BD&L function or relevant corporate positions within the Life Sciences Industry (Business Development/Venture Capital/Private Equity/Investment Banking)
Firm understanding of the general drug discovery, development and commercialization process is a requirement
Previous exposure to nephrology or heart failure is considered an additional asset
Help in the advancement of the team, the development of new skills and the continuous improvement of quality
Excellent oral and written communication skills in English and German
Good story-telling capabilities
Entrepreneurial spirit and can-do attitude
You are self-motivated, proactive, and have a result-driven personality and are ready to step into action when required. You have an open and communicative personality, which fits well with your ability to work in interdisciplinary teams. You have high client orientation and a passion for close collaboration with a wide range of stakeholders. Your ability to deliver high quality work under time pressure reflects your interest in working in a dynamic and international work environment such as Vifor Pharma.
Die Vifor Pharma Gruppe ist ein globales Spezialitäten-Pharmaunternehmen. Sie hat sich zum Ziel gesetzt, globale Marktführerin in den Bereichen Eisenmangel, Nephrologie und kardiorenale Therapien zu werden. Das Unternehmen ist der bevorzugte Partner für Pharmaprodukte und innovative, patientenorientierte Lösungen. Die Vifor Pharma Gruppe will Patienten mit schweren und chronischen Krankheiten auf der ganzen Welt dabei helfen, ein Leben in besserer Gesundheit zu führen. Das Unternehmen entwickelt, produziert und vermarktet pharmazeutische Produkte für eine optimale Patientenversorgung. Die Vifor Pharma Gruppe nimmt in allen ihren Kerngeschäften eine führende Position ein und besteht aus folgenden Unternehmen: Vifor Pharma, Vifor Fresenius Medical Care Renal Pharma (ein gemeinsam mit Fresenius Medical Care geführtes Unternehmen); und OM Pharma.
Die Vifor Pharma Gruppe hat ihren Hauptsitz in der Schweiz und ist an der Schweizer Börse (SIX Swiss Exchange, VIFN, ISIN: CH0364749348) kotiert.